BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Allucent Secures $25.5 Million Award for Decentralized COVID-19 Trial

Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million...

May 16, 2024 | News

Mabwell Advances Clinical Study of Nectin-4-Targeting ADC for Triple-Negative Breast Cancer

Mabwell, an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targ...

May 14, 2024 | News

Touchlight Genetics and NPL Receive Innovate UK Funding for Advanced Gene Therapy Technology

Touchlight Genetics, in partnership with the National Physical Laboratory (NPL) have secured funding from Innovate UK under their Innovative Technologies: ...

May 13, 2024 | News

Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open ...

May 08, 2024 | News

FDA Approves Geneoscopy's Noninvasive Colorectal Cancer Test, ColoSense

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced that the U...

May 07, 2024 | News

Agilent Introduces NovoCyte Opteon Spectral Flow Cytometer, Redefining Flow Cytometry Standards

Agilent has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system ...

May 06, 2024 | News

HanAll Launches Phase III VELOS-4 Trial for Tanfanercept in Dry Eye Treatment

HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Pha...

May 06, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

May 03, 2024 | News

Everest Medicines Secures NDA Approval for Nefecon® in Hong Kong, Expanding Treatment Reach in Asia

Everest Medicines announced that the Hong Kong Department of Health had approved Nefecon® for the treatment of primary immunoglobulin A nephropath...

May 02, 2024 | News

AstraZeneca Highlights Key Respiratory and Immune Research at ATS 2024

AstraZeneca will present new clinical and real-world data from its expansive respiratory portfolio at the American Thoracic Society (ATS) International Con...

May 02, 2024 | News

Infinitopes Raises £12.8M to Expand Precision Immunomics™ for Five Additional Cancers

- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen disco...

May 01, 2024 | News

AstraZeneca's ENHERTU Shows Breakthrough in Treating HR-Positive, HER2-Low Breast Cancer in Latest Trial

Positive high-level results from the DESTINY-Breast06 Phase III trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statis...

April 30, 2024 | News

WuXi AppTec Reports First Quarter 2024 Financial Results: Solid Performance with Continued Growth in R&D Services

First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...

April 30, 2024 | Company results

FDA Approves Ractigen Therapeutics' IND for Groundbreaking Bladder Cancer Therapy

Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration...

April 29, 2024 | News

Stay Connected